| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 12/05/2007 | EP1305329B1 6.alpha.,9.alpha.-difluoro-17.alpha.-(2-furanylcarboxyl)oxy-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 12/05/2007 | CN101084227A Rapamycin analogues and the uses thereof in the treatment of neurological disorders |
| 12/05/2007 | CN101083984A Therapeutic compositions for intranasal administration of ketorolac |
| 12/05/2007 | CN101081863A Lipopolysaccharide conjugated protein and monoclonal antibody and preparation method and usage |
| 12/05/2007 | CN101081834A Process for the preparation of leukotriene antagonists |
| 12/05/2007 | CN101081296A Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof |
| 12/05/2007 | CN101081290A Chinese medicinal material preparation for relieving pain |
| 12/05/2007 | CN101081255A kazukiyo oral liquid agent and its preparing process |
| 12/05/2007 | CN101081254A Notoginseng vulnerary extract and method for making same and application |
| 12/05/2007 | CN101081223A Application of 2, 2'-bipyridine N- oxide disulfide in the preparing of antiphlogistic medicine |
| 12/05/2007 | CN101081218A Rapid-disintegrated oral film and method for making same |
| 12/05/2007 | CN101081092A beverage for expelling toxin and treating melancholy |
| 12/05/2007 | CN101081091A Vision-improving and intelligent-improving beverage |
| 12/05/2007 | CN100352923C Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 12/05/2007 | CN100352921C Compositions and methods for identifying antigens which elicit an immune response |
| 12/05/2007 | CN100352844C Recombinant anti-osteopontin antibody and use thereof |
| 12/05/2007 | CN100352843C Kdr peptides and vaccines comprising the same |
| 12/05/2007 | CN100352840C Nucleus factor-kB p50 subunit combination peptide, preparation and application thereof |
| 12/05/2007 | CN100352816C Nociceptin analogs |
| 12/05/2007 | CN100352807C Chemical compounds |
| 12/05/2007 | CN100352804C 酰胺衍生物 Amide derivatives |
| 12/05/2007 | CN100352496C Lugua polypeptides for injection and its preparing process |
| 12/05/2007 | CN100352494C Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 12/05/2007 | CN100352489C Dog bone contained composition for treating rheumatoid arthritis |
| 12/05/2007 | CN100352477C Wound healing medicine |
| 12/05/2007 | CN100352444C A process for the preparation of piroxicam: beta-cyclodextrin inclusion compounds |
| 12/05/2007 | CN100352443C Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 12/05/2007 | CN100352433C Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 12/05/2007 | CN100352431C Pharmaceutical salts |
| 12/05/2007 | CN100352430C Self microemulsifying preparation of curcumin and its preparing process |
| 12/04/2007 | US7304174 CaSR antagonist |
| 12/04/2007 | US7304083 2-iminoimidazole derivatives (2) |
| 12/04/2007 | US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents |
| 12/04/2007 | US7304078 Thrombosis; cardiovascular disorders; restenosis; hypotensive agents; antiarrhythmia agents; antiinflamamtroy agents; central nervous system disorders |
| 12/04/2007 | US7304077 Asthma, rhinitis therapy |
| 12/04/2007 | US7304072 Spiro compounds |
| 12/04/2007 | US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds |
| 12/04/2007 | US7304066 Pyridyl cyanoguanidine compounds |
| 12/04/2007 | US7304064 1-[(indol-3-yl)carbonyl]piperazine derivatives |
| 12/04/2007 | US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment |
| 12/04/2007 | US7304059 Substituted quinazolin-4-ylamine analogues |
| 12/04/2007 | US7304039 Glucose-based compounds with affinity to P-selectin |
| 12/04/2007 | US7304033 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules |
| 12/04/2007 | US7304031 Methods and means for producing proteins with predetermined post-translational modifications |
| 12/04/2007 | US7303889 Ligand for G-protein coupled receptor GPR43 and uses thereof |
| 12/04/2007 | US7303885 For treating or detecting MIF (macrophage migration inhibitor factor) related diseases by detecting MIF/Jab1 (c-Jun activation domain binding protein) interactions; complex MIF in natural association with Jab1 and optionally another protein |
| 12/04/2007 | US7303739 Cyclic phosph(oramid)ate prodrugs having alcohol, amine, orthiol groups attached to phosphorus; camptothecins; pharmacodynamic half-life; diagnostic imaging |
| 12/04/2007 | CA2337800C Farnesyl protein transferase inhibitors for treating arthropathies |
| 12/04/2007 | CA2276170C Sustained analgesia achieved with buprenorphine |
| 12/04/2007 | CA2212205C Use of xanthine derivatives for the modulation of apoptosis |
| 11/29/2007 | WO2007137220A2 Compositions and methods for inhibiting expression of ikk-b gene |
| 11/29/2007 | WO2007135781A1 Peptide capable of enhancing the activity of ephrin-b2, salt thereof, composition for medical purposes, kit for therapy |
| 11/29/2007 | WO2007135505A2 Veterinary pharmaceutical compositions for the treatment of pain and inflammation |
| 11/29/2007 | WO2007135463A1 Optical enantiomers of phenyramidol and process for chiral synthesis |
| 11/29/2007 | WO2007135195A1 Ectonucleotidase inhibitors |
| 11/29/2007 | WO2007135027A1 Substituted pteridines substituted with a four-membered heterocycle |
| 11/29/2007 | WO2007134538A1 Rat antihuman macrophage migration inhibitory factor monoclonal antibody and its application |
| 11/29/2007 | WO2007134451A1 Oligonucleotides affecting expression of phosphodiesterases |
| 11/29/2007 | WO2007120647A3 Compositions useful as inhibitors of voltage-gated sodium channels |
| 11/29/2007 | WO2007090836A3 Piperidine derivatives as cxcr3 receptor antagonists |
| 11/29/2007 | WO2007085629A3 Use of hyaluronic acid as a carrier molecule for?different classes of therapeutic active agents |
| 11/29/2007 | WO2007085019A3 Methods of treating or preventing sinusitis with oxidative reductive potential water solution |
| 11/29/2007 | WO2007085018A3 Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution |
| 11/29/2007 | WO2007078335A3 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 11/29/2007 | WO2007052172A3 Methods for fusion polypeptide delivery into a cell |
| 11/29/2007 | WO2007038453A3 Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation |
| 11/29/2007 | WO2007034465A3 Use of il-1f5 for the modulation of an immune-mediated response |
| 11/29/2007 | US20070276043 3-(p-Substituted alkoxyphenyl)-2-(o-benzoylanilino)propionic acid derivatives, e.g., 2-(o-Benzoylphenylamino)-3-(p-{2-[(o-fluorophenyl)isobutylamino]-ethoxy}phenyl)propionic acid; for treating non-insulin dependent diabetes and obesity |
| 11/29/2007 | US20070276040 Peptidyl Arginine Deiminase Type IV Inhibitor |
| 11/29/2007 | US20070276039 Pharmaceutical uses for alpha2delta ligands |
| 11/29/2007 | US20070275989 Therapeutic Treatment |
| 11/29/2007 | US20070275965 CXCR4 modulators |
| 11/29/2007 | US20070275964 Cannabinoid receptor ligands and uses thereof |
| 11/29/2007 | US20070275935 Estratriene Derivatives |
| 11/29/2007 | US20070275903 oligopeptide conjugates; cleavable by trouase such as Thimet oligopeptidase; antitumor agents |
| 11/29/2007 | US20070275890 Chaperonin 10 Modulation Of Toll-Like Receptor-Inducible Cytokine And Chemokine Secretion |
| 11/29/2007 | US20070275095 Treatment of inflammatory, autoimmune, or other disorders, using agents that reduce the sequestering of zinc by calprotectin |
| 11/29/2007 | US20070275093 Methods for Treating Non-Microbial Inflammatory Skin Conditioners |
| 11/29/2007 | US20070275004 Group b streptococcus antigens |
| 11/29/2007 | US20070274974 Compositions and methods for restoring immune responsiveness in patients with immunological defects |
| 11/29/2007 | US20070274910 e.g. 3-[2-(2-Aminophenyl)ethyl]-8-benzyl-7-(2-methylamino)ethyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 11/29/2007 | DE19531342B4 Verwendung von Aminoadamantan-Verbindungen als Immunregulatoren Use of aminoadamantane compounds as immune regulators |
| 11/29/2007 | DE102006024911A1 Solubilizate of plant extract that contains active agent, useful as additive for e.g. cosmetics, pharmaceuticals and foods, includes water and emulsifier |
| 11/29/2007 | DE102006024834A1 Neue Indol-Pyrrol-Derivate und deren Verwendung New indole-pyrrole derivatives and their use |
| 11/29/2007 | CA2653117A1 Substituted pteridines substituted with a four-membered heterocycle |
| 11/29/2007 | CA2652539A1 Oligonucleotides affecting expression of phosphodiesterases |
| 11/29/2007 | CA2652537A1 Veterinary pharmaceutical compositions for the treatment of pain and inflammation |
| 11/28/2007 | EP1860113A1 Ectonucleotidase inhibitors |
| 11/28/2007 | EP1860109A1 Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders |
| 11/28/2007 | EP1860108A1 Enantiomers of Amino Pyrimidine compounds for the treatment of inflammatory disorders |
| 11/28/2007 | EP1860106A1 Tricyclic thrombin receptor antagonists |
| 11/28/2007 | EP1860100A2 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 11/28/2007 | EP1859834A1 Anti-inflammatory agent |
| 11/28/2007 | EP1859811A1 Use of conjugates of amatoxins or phallotoxins with macromolecules for tumor and inflammation therapy |
| 11/28/2007 | EP1858874A1 (s)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine-di-p-toluoyl-l-tartarate and methods of preparation thereof |
| 11/28/2007 | EP1858873A2 Process for the purification of duloxetine hydrochloride |
| 11/28/2007 | EP1858872A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists |
| 11/28/2007 | EP1858859A1 Process for the preparation of optically active (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine |
| 11/28/2007 | EP1858592A2 Treatment of inflammatory bowel disease |
| 11/28/2007 | EP1858556A1 Vehicle for topical delivery of anti-inflammatory compounds |